Senate does not negotiate with Baucus
Executive Summary
Medicare direct drug price negotiation bill stalls in the Senate April 18, as Sen. Max Baucus, D-Mont., fails to win enough votes for "cloture," which would bring the Senate to a vote. As passed by the Finance Committee, Baucus' S 3 would permit HHS to negotiate Part D prices with drug manufacturers and add provisions in other areas such as comparative effectiveness research and data sharing with congressional agencies (1"The Pink Sheet" April 16, 2007, p. 4)...